A Trademark

Trademark Overview


On Tuesday, May 9, 2023, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 97928168. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, April 12, 2024. This trademark is owned by Athira Pharma, Inc.. The A trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Prescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis

Pharmaceutical research and development; pharmaceutical drug development services
a

General Information


Serial Number97928168
Word MarkA
Filing DateTuesday, May 9, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, April 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 30, 2024

Trademark Statements


Description of MarkThe mark consists of the a stylized letter "A" consisting of an incomplete star with a circle at the end of three of the points.
Goods and ServicesPrescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development; pharmaceutical drug development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAthira Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBothell, WA 98011

Party NameAthira Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98011

Trademark Events


Event DateEvent Description
Friday, April 12, 2024SOU EXTENSION 1 GRANTED
Friday, April 12, 2024SOU EXTENSION 1 FILED
Friday, April 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 30, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 21, 2023ASSIGNED TO EXAMINER
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 12, 2023NEW APPLICATION ENTERED